Diabetes decisions — 2025

The Board denied increased ratings for diabetic peripheral neuropathy, diabetes mellitus, and knee limitations but granted separate 10 percent ratings for left and right knee flexion due to pain.

The Board remands the claims for service connection for diabetes and related conditions due to a duty to assist error.

The Board denied service connection for various conditions, including glaucoma, diabetes, and neuropathy, as the probative evidence did not support a finding that these conditions were incurred in or caused by active military service.

The Board denied the veteran's claims for survivor's pension, accrued benefits, and dependency and indemnity compensation under 38 U.S.C. § 1318 due to the appellant's countable income exceeding the applicable maximum annual pension rates and the Veteran not having any unpaid VA benefits or claims pending at the time of his death.

The Board remands the claim for service connection of the Veteran's cause of death due to a presumed exposure to herbicides during his service in Vietnam.

The Board denied the veteran's claims for a compensable rating for bilateral hearing loss, earlier effective dates for prostate cancer and erectile dysfunction, dismissed incontinence, and remanded diabetes and COPD. Prostate cancer was granted with an initial 100% rating from January 6, 2020.

The Board denied several claims for increased ratings and granted some, including a 20% rating for right ankle arthritis from April 2, 2022, and separate 30% ratings for left and right knee ankylosis starting May 23, 2022.

The Board denied service connection for diabetes mellitus, non-Hodgkin's lymphoma, and hypertension as the evidence did not support a finding that these conditions were related to in-service herbicide exposure.

The appeal for service connection for diabetes mellitus, type II has been dismissed by the Veteran.

The Board denied the veteran's claims for service connection for various conditions, finding no new and relevant evidence to support a change in previous denials.

The Board granted restoration of the 10 percent disability rating for bilateral knee patellofemoral syndrome and denied service connection for diabetes mellitus type II.

The Board denied service connection for high cholesterol and remanded the claims for prostate cancer, arthritis, diabetes type II, end stage renal disease on dialysis, nerve pain (including diabetic neuropathy), and kidney cancer for further development.

The Board granted service connection for type II diabetes mellitus as secondary to the Veteran's service-connected major depressive disorder with unspecified anxiety disorder, traumatic brain injury, and right ankle sprain.

The Board granted an effective date of February 16, 2001, but no earlier, for the award of service connection for diabetes mellitus, type II, and denied an effective date prior to June 22, 2000, for the award of service connection for coronary artery disease (CAD).

The Board granted an initial disability rating of 10 percent for hypertension and denied a higher rating, while remanding several service connection claims.

The Board granted service connection for tinnitus and obstructive sleep apnea (OSA) but denied it for sinusitis. The remaining claims were remanded.

The Board granted service connection for sinusitis and dismissed the appeal for chronic fatigue syndrome. The claim for type 2 diabetes mellitus was remanded.

The Board remands the claims for an earlier effective date for TDIU and SMC at the housebound rate due to errors by the RO in satisfying a regulatory duty under 4.16(b).

The Board remands the claims for service connection for obesity, anemia, diabetes mellitus (type II), heart disease, hypertension, and sleep apnea as they require further development of evidence.

The Board denied an earlier effective date for the award of service connection for diabetes mellitus type II, hypertension, and congestive heart failure and cardiomyopathy with automatic implantable cardioverter defibrillator prior to August 10, 2022.